Protalix BioTherapeutics
PLX
#8907
Rank
A$0.21 B
Marketcap
A$2.63
Share price
0.58%
Change (1 day)
-4.44%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): A$13.98 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$61.94 Million. In 2024 the company made an earning of A$7.87 Million a decrease over its 2023 earnings that were of A$17.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$13.98 M77.55%
2024 A$7.87 M-55.62%
2023 A$17.75 M-199.05%
2022 -A$17.93 Million-40.38%
2021 -A$30.07 Million-732.31%
2020 A$4.75 M-130.53%
2019 -A$15.58 Million189.85%
2018 -A$5.38 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$27.96 Million-32.37%
2015 -A$41.34 Million10.11%
2014 -A$37.55 Million-7.59%
2013 -A$40.63 Million
2011 -A$47.05 Million-19.39%
2010 -A$58.37 Million20.87%
2009 -A$48.29 Million32.26%
2008 -A$36.51 Million-5.46%
2007 -A$38.62 Million
2004 -A$0.26 Million12.35%
2003 -A$0.23 Million-11.1%
2002 -A$0.26 Million-57.03%
2001 -A$0.59 Million1.03%
2000 -A$0.58 Million-53.22%
1999 -A$1.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
A$7.52 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.88 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.90 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.67 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel